Biblio

Export 6 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Female  [Clear All Filters]
2014
Shi Q, Ghosh RP, Engelke H, Rycroft CH, Cassereau L, Sethian JA, Weaver VM, Liphardt JT.  2014.  Rapid disorganization of mechanically interacting systems of mammary acini.. Proc Natl Acad Sci U S A. 111(2):658-63.
2013
Pickup MW, Laklai H, Acerbi I, Owens P, Gorska AE, Chytil A, Aakre M, Weaver VM, Moses HL.  2013.  Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.. Cancer Res. 73(17):5336-46.
Maller O, DuFort CC, Weaver VM.  2013.  YAP forces fibroblasts to feel the tension.. Nat Cell Biol. 15(6):570-2.
2011
Lopez JI, Kang I, You W-K, McDonald DM, Weaver VM.  2011.  In situ force mapping of mammary gland transformation.. Integr Biol (Camb). 3(9):910-21.
Dvorak HF, Weaver VM, Tlsty TD, Bergers G.  2011.  Tumor microenvironment and progression.. J Surg Oncol. 103(6):468-74.
2010
Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, Benezra M, Licht JD, Boudreau NJ, Tsai KKC et al..  2010.  HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype.. J Clin Invest. 120(5):1535-50.
Cohet N, Stewart KM, Mudhasani R, Asirvatham AJ, Mallappa C, Imbalzano KM, Weaver VM, Imbalzano AN, Nickerson JA.  2010.  SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.. J Cell Physiol. 223(3):667-78.
2009
Vasilatos SN, Broadwater G, Barry WT, Baker JC, Lem S, Dietze EC, Bean GR, Bryson AD, Pilie PG, Goldenberg V et al..  2009.  CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis.. Cancer Epidemiol Biomarkers Prev. 18(3):901-14.
Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SFT, Csiszar K, Giaccia A, Weninger W et al..  2009.  Matrix crosslinking forces tumor progression by enhancing integrin signaling.. Cell. 139(5):891-906.
2007
Kass L, Erler JT, Dembo M, Weaver VM.  2007.  Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis.. Int J Biochem Cell Biol. 39(11):1987-94.
2002
Weaver VM, Lelièvre S, Lakins JN, Chrenek MA, Jones JCR, Giancotti F, Werb Z, Bissell MJ.  2002.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.. Cancer Cell. 2(3):205-16.
Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW.  2002.  The organizing principle: microenvironmental influences in the normal and malignant breast.. Differentiation. 70(9-10):537-46.
2001
Chrenek MA, Wong P, Weaver VM.  2001.  Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation.. Breast Cancer Res. 3(4):224-9.
1998
Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ.  1998.  Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology.. Proc Natl Acad Sci U S A. 95(25):14821-6.
Schmeichel KL, Weaver VM, Bissell MJ.  1998.  Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.. J Mammary Gland Biol Neoplasia. 3(2):201-13.
Lelièvre SA, Weaver VM, Nickerson JA, Larabell CA, Bhaumik A, Petersen OW, Bissell MJ.  1998.  Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus.. Proc Natl Acad Sci U S A. 95(25):14711-6.
1997
Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ.  1997.  Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.. J Cell Biol. 137(1):231-45.